journal of pediatric endocrinology & metabolism : jpem2021pp. -
116
a2021journalretrospective
Abstract
Patients with X-ALD should be carefully followed up for cerebral findings and progression, since there is no genotype-phenotype correlation, and the clinical course cannot be predicted by family history. HSCT is the only available treatment option for patients with neurological deterioration.